NO20042910L - Fremgangsmate for fremstilling av virusantigen i stor skala - Google Patents

Fremgangsmate for fremstilling av virusantigen i stor skala

Info

Publication number
NO20042910L
NO20042910L NO20042910A NO20042910A NO20042910L NO 20042910 L NO20042910 L NO 20042910L NO 20042910 A NO20042910 A NO 20042910A NO 20042910 A NO20042910 A NO 20042910A NO 20042910 L NO20042910 L NO 20042910L
Authority
NO
Norway
Prior art keywords
production method
large scale
virus antigen
antigen production
scale virus
Prior art date
Application number
NO20042910A
Other languages
English (en)
Inventor
Wolfgang Mundt
Manfred Reiter
Original Assignee
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21723079&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20042910(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Healthcare Sa filed Critical Baxter Healthcare Sa
Publication of NO20042910L publication Critical patent/NO20042910L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
NO20042910A 2001-12-10 2004-07-09 Fremgangsmate for fremstilling av virusantigen i stor skala NO20042910L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/006,881 US6951752B2 (en) 2001-12-10 2001-12-10 Method for large scale production of virus antigen
PCT/EP2002/014011 WO2003054174A1 (en) 2001-12-10 2002-12-10 Method for large scale production of virus antigen

Publications (1)

Publication Number Publication Date
NO20042910L true NO20042910L (no) 2004-07-09

Family

ID=21723079

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042910A NO20042910L (no) 2001-12-10 2004-07-09 Fremgangsmate for fremstilling av virusantigen i stor skala

Country Status (18)

Country Link
US (2) US6951752B2 (no)
EP (3) EP1453956B2 (no)
JP (2) JP4370511B2 (no)
CN (2) CN101100657B (no)
AT (1) ATE447010T2 (no)
AU (1) AU2002358662B2 (no)
CA (1) CA2469644C (no)
DE (2) DE122010000025I1 (no)
DK (2) DK1453956T3 (no)
ES (2) ES2488818T3 (no)
FR (1) FR10C0026I1 (no)
HK (2) HK1115609A1 (no)
HU (1) HU225791B1 (no)
MX (1) MXPA04005644A (no)
NO (1) NO20042910L (no)
PL (1) PL208232B1 (no)
RU (1) RU2314344C2 (no)
WO (1) WO2003054174A1 (no)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7445924B2 (en) * 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
US6951752B2 (en) * 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen
EA006485B1 (ru) * 2001-12-20 2005-12-29 Бавариан Нордик А/С Способ выделения и очистки поксвирусов из инфицированных клеток
NZ538575A (en) 2002-09-05 2007-03-30 Bavarian Nordic As Method for the amplification of a virus wherein primary avian cells are cultivated in a serum-free medium comprising growth factors and attachment factors
CN101857851A (zh) * 2002-12-23 2010-10-13 布里斯托尔-迈尔斯斯奎布公司 用于蛋白质生产的哺乳动物细胞培养方法
JP2007515172A (ja) * 2003-12-23 2007-06-14 シェーリング　コーポレイション 無血清培地懸濁培養において安定なａ５４９細胞株を生成するための方法
ES2329607T3 (es) 2004-02-23 2009-11-27 Crucell Holland B.V. Metodos de purificacion de virus.
EP1739167B1 (en) * 2004-04-19 2015-08-12 DENKA SEIKEN Co., Ltd. Method of producing virus
RU2006145303A (ru) * 2004-05-20 2008-06-27 АйДи БАЙОМЕДИКАЛ КОРПОРЕЙШН (CA) Способ получения противогриппозной вакцины
US7344839B2 (en) * 2004-12-23 2008-03-18 Aurx, Inc. Virus preparations and methods
AU2005322353B2 (en) 2004-12-23 2011-09-01 Medimmune, Llc Non-tumorigenic MDCK cell line for propagating viruses
WO2007126810A2 (en) 2006-03-31 2007-11-08 Warf - Wisconsin Alumni Research Foundation High titer recombinant influenza viruses for vaccines
CN103361319A (zh) 2006-09-15 2013-10-23 米迪缪尼有限公司 支持病毒生长到高效价的mdck细胞系和采用该细胞系的生物反应器方法
JP5084214B2 (ja) * 2006-09-29 2012-11-28 一般財団法人日本ポリオ研究所 Ｉｐｖワクチン
MX2009011899A (es) * 2007-05-04 2010-03-30 Baxter Int Perfil de temperatura de dos pasos para la propagacion de virus.
US9474798B2 (en) 2007-06-18 2016-10-25 Wisconsin Alumni Research Foundation Influenza M2 protein mutant viruses as live influenza attenuated vaccines
US20110014624A1 (en) * 2008-03-12 2011-01-20 Wyeth Llc Methods For Identifying Cells Suitable For Large-Scale Production of Recombinant Proteins
JP5689796B2 (ja) * 2008-08-01 2015-03-25 ガマ ワクチンズ ピーティワイ リミテッド インフルエンザワクチン
EP2334328A4 (en) 2008-09-24 2012-08-29 Medimmune Llc METHOD FOR CLEANING VIRUSES
CN103952376A (zh) 2008-09-24 2014-07-30 米迪缪尼有限公司 培养细胞、增殖和纯化病毒的方法
CA2768997C (en) 2009-07-31 2017-09-12 Xcellerex, Inc. High yield yellow fever virus strain with increased propagation in cells
JP2013507990A (ja) 2009-10-26 2013-03-07 ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション ベロ細胞において増強された複製を有する高力価の組換えインフルエンザウイルス
BR112012015596B1 (pt) * 2009-12-23 2021-06-01 Sanofi Pasteur Processo de cultura de células aderentes
US10130697B2 (en) 2010-03-23 2018-11-20 Wisconsin Alumni Research Foundation (Warf) Vaccines comprising mutant attenuated influenza viruses
BR112012026095A2 (pt) 2010-04-14 2015-09-15 Emd Millipore Corp métodos de produção de estoques de vírus de alta pureza e altos títulos e métodos de uso dos mesmos.
WO2012048275A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
CN101979517B (zh) * 2010-10-15 2011-12-28 普莱柯生物工程股份有限公司 一种利用生物反应器大规模生产流感病毒的方法
EP2667891B1 (en) 2011-01-27 2021-10-06 Gamma Vaccines Pty Limited Combination vaccines
CN102492659A (zh) * 2011-11-14 2012-06-13 成都康华生物制品有限公司 一种疫苗生产用甲肝病毒的生产方法
EP3022296B1 (en) 2013-07-15 2022-12-28 Wisconsin Alumni Research Foundation High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs
CN103387958B (zh) * 2013-08-16 2016-04-06 北京科兴中维生物技术有限公司 人胚肺成纤维细胞sv-7在病毒培养中的应用
JP6612227B2 (ja) 2013-11-16 2019-11-27 テルモ ビーシーティー、インコーポレーテッド バイオリアクターにおける細胞増殖
EP3122866B1 (en) 2014-03-25 2019-11-20 Terumo BCT, Inc. Passive replacement of media
WO2015196150A2 (en) 2014-06-20 2015-12-23 Wisconsin Alumni Research Foundation (Warf) Mutations that confer genetic stability to additional genes in influenza viruses
JP6830059B2 (ja) 2014-09-26 2021-02-17 テルモ ビーシーティー、インコーポレーテッド スケジュール化された細胞フィーディング
JP6288311B2 (ja) 2015-01-26 2018-03-07 宇部興産株式会社 物質の産生方法
CA2969197C (en) 2015-01-26 2020-08-18 Ube Industries, Ltd. Method, device and kit for mass cultivation of cells using polyimide porous membrane
US10633422B2 (en) 2015-06-01 2020-04-28 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US9890363B2 (en) 2015-07-06 2018-02-13 Wisconsin Alumni Research Foundation (Warf) Influenza virus replication for vaccine development
US11197925B2 (en) 2016-02-19 2021-12-14 Wisconsin Alumni Research Foundation (Warf) Influenza B virus replication for vaccine development
JP7034949B2 (ja) 2016-05-25 2022-03-14 テルモ ビーシーティー、インコーポレーテッド 細胞の増殖
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
EP3489342B1 (en) 2016-07-25 2022-01-26 UBE Industries, Ltd. Siphon type cultivation method
KR102307420B1 (ko) 2016-07-25 2021-09-29 우베 고산 가부시키가이샤 세포 배양 모듈
CN110612344B (zh) 2017-03-31 2023-09-12 泰尔茂比司特公司 细胞扩增
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP3740234A1 (en) * 2018-01-18 2020-11-25 Yisheng Biopharma (Singapore) Pte. Ltd. Method for adapting influenza viruses to vero cells
US11911457B2 (en) 2018-02-07 2024-02-27 Bharat Biotech International Limited Process for enterovirus purification and inactivation and vaccine compositions obtained thereof
EP3914295A2 (en) 2019-01-23 2021-12-01 Yoshihiro Kawaoka Mutations that confer genetic stability to additional genes in influenza viruses
KR102228267B1 (ko) * 2019-01-25 2021-03-17 바이로큐어 주식회사 Bhk-21 세포를 이용한 바이러스 생산방법
WO2020153619A1 (ko) * 2019-01-25 2020-07-30 바이로큐어 주식회사 Bhk-21 세포를 이용한 바이러스 생산방법
CN113874496A (zh) 2019-02-08 2021-12-31 威斯康星校友研究基金会(Warf) 人源化细胞系
US20220098555A1 (en) * 2019-02-15 2022-03-31 Ology Bioservices, Inc. Method for virus production
CN114929269A (zh) 2019-05-01 2022-08-19 威斯康星校友研究基金会(Warf) 用于疫苗开发的改进的流感病毒复制
TW202122572A (zh) 2019-08-09 2021-06-16 日商宇部興產股份有限公司 胞外體的產生方法
TW202122569A (zh) 2019-08-09 2021-06-16 日商宇部興產股份有限公司 應用小片多孔膜的細胞培養法
WO2021041624A2 (en) 2019-08-27 2021-03-04 Yoshihiro Kawaoka Recombinant influenza viruses with stabilized ha for replication in eggs
CN111850169B (zh) * 2020-07-16 2022-09-27 华农（肇庆）生物产业技术研究院有限公司 一种计算AIV在MDCK-sus细胞中细胞单位均产毒量的方法
GB2619893A (en) 2021-03-23 2023-12-20 Terumo Bct Inc Cell capture and expansion

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4525349A (en) 1981-12-29 1985-06-25 Societe Anonyme Dite: Institut Merueux Process for the large-scale production of a vaccine against poliomyelitis and the resulting vaccine
AT393356B (de) 1989-12-22 1991-10-10 Immuno Ag Verfahren zur herstellung von fsme-virus-antigen
US5719051A (en) * 1989-12-22 1998-02-17 Immuno Aktiengesellschaft Perfusion system and a method for the large scale production of virus or virus antigen
FR2723740B1 (fr) 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
EP2290053A1 (en) 1994-11-10 2011-03-02 Baxter Healthcare S.A. Method for producing Influenza virus in protein-free cell culture medium
DE19612966B4 (de) * 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
GB2319413B (en) * 1996-11-12 2001-06-06 Lsi Logic Corp Driver circuits
US6168944B1 (en) * 1997-01-31 2001-01-02 Schering Corporation Methods for cultivating cells and propagating viruses
EP1731598A1 (en) * 1997-01-31 2006-12-13 Schering Corporation Methods for cultivating cells and propagating viruses
AT407255B (de) 1997-06-20 2001-02-26 Immuno Ag Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons
US5994134A (en) * 1998-05-04 1999-11-30 Canji, Inc. Viral production process
US6951752B2 (en) * 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen
US6855535B2 (en) * 2001-12-10 2005-02-15 Baxter Healthcare S.A. Method of large scale production of Hepatitis A virus

Also Published As

Publication number Publication date
JP2005512564A (ja) 2005-05-12
ES2488818T3 (es) 2014-08-29
US20050181495A1 (en) 2005-08-18
EP1894998A8 (en) 2008-04-23
CA2469644A1 (en) 2003-07-03
JP2009261410A (ja) 2009-11-12
RU2004121178A (ru) 2005-10-10
US20030108860A1 (en) 2003-06-12
ES2335395T3 (es) 2010-03-26
JP5021000B2 (ja) 2012-09-05
DK2330189T3 (da) 2014-06-16
EP2330189B1 (en) 2014-05-21
FR10C0026I1 (fr) 2011-01-14
EP1453956A1 (en) 2004-09-08
WO2003054174A1 (en) 2003-07-03
CA2469644C (en) 2013-07-23
EP1453956B1 (en) 2009-10-28
EP1453956B2 (en) 2017-01-18
JP4370511B2 (ja) 2009-11-25
US7524676B2 (en) 2009-04-28
CN101100657B (zh) 2012-05-30
DE60234211D1 (de) 2009-12-10
HK1158691A1 (en) 2012-07-20
CN100335619C (zh) 2007-09-05
EP2330189A1 (en) 2011-06-08
AU2002358662A1 (en) 2003-07-09
PL208232B1 (pl) 2011-04-29
MXPA04005644A (es) 2005-04-19
PL373487A1 (en) 2005-09-05
CN101100657A (zh) 2008-01-09
DK1453956T3 (da) 2010-01-11
EP1453956B8 (en) 2010-02-10
HUP0402415A2 (hu) 2005-02-28
RU2314344C2 (ru) 2008-01-10
HUP0402415A3 (en) 2005-07-28
EP1894998A1 (en) 2008-03-05
HK1115609A1 (en) 2008-12-05
HU225791B1 (en) 2007-09-28
CN1617924A (zh) 2005-05-18
US6951752B2 (en) 2005-10-04
AU2002358662B2 (en) 2008-05-15
ES2335395T5 (es) 2017-08-31
ATE447010T2 (de) 2009-11-15
DE122010000025I1 (de) 2010-08-12

Similar Documents

Publication Publication Date Title
NO20042910L (no) Fremgangsmate for fremstilling av virusantigen i stor skala
El-Fadel et al. A numerical model for methane production in managed sanitary landfills
ATE526395T1 (de) Verwendung von il-7 und il-15 zur genetischen modifizierung von gedächtnis-t-lymphozyten
ATE452181T1 (de) Verfahren und vorrichtung zur haltung und expansion von hematopoietischen stammzellen und/oder vorläuferzellen
YU83101A (sh) Postupci i materijali za sinteze organskih proizvoda
ATE208810T1 (de) Solid-state-fermenter und verfahren zur solid- state-fermentation
ATE398170T1 (de) Kultur von zellen
DK2202206T3 (da) Styring af udvikling af biofilm i industrielt procesvand
DK112686D0 (da) Fremgangsmaade og apparat til dyrkning af cellekulturer
DK0414475T3 (da) Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier
HK1093755A1 (en) Method for differentiating mesenchymal stem cell into neural cell
ATE307599T1 (de) Keratinozyt-abstammende granulate zur verwendung als wundheilendes mittel
DE60307615D1 (de) Zellkulturmedium
ATE330003T1 (de) Rekombinanter stabiler zellklon, seine herstellung und verwendung
ATE530657T1 (de) Verfahren zur herstellung von zellinien mit latentem immunschwächevirus
ATE520024T1 (de) Patch-clamp-verfahren und seine verwendung zur untersuchung subzellulärer merkmale
ATE421573T1 (de) Verfahren zur herstellung von gamma delta t zellen
Pareek et al. Mathematical modeling and simulation of methane gas production in simulated landfill column reactors under sulfidogenic and methanogenic environments
EP1676911A4 (en) NEW RECOMBINANT ANIMAL CELLS WITH HIGH PROTEIN PRODUCTION, CORRESPONDING FIXING METHOD AND METHOD FOR PREPARING MASS PROTEINS USING THE SAME
SE9904125D0 (sv) Detection method
Gotovtsev et al. Synthetic biology as a bridge to integration of bio objects into Internet of Things
Gawande et al. Modeling microbiological and chemical processes in municipal solid waste bioreactor, part II: Application of numerical model BIOKEMOD-3P
FR2857671B1 (fr) Nouveau procede de culture de keratinocytes et ses applications
ATE132896T1 (de) Methoden zur verwendung von an humanen klasse-ii- histokompatibilitätsantigenen mangelnden zellinien
ATE288476T1 (de) Herstellung von proteinen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application